Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who already have a right-sided heart pacemaker, where the heart's pumping function (measured as a percentage called ejection fraction) is between 35% and 50%, and the pacemaker is being used heavily (more than 40% of the time)
- People whose doctor has recommended upgrading their pacemaker to a more advanced type that helps both sides of the heart beat in sync (called cardiac resynchronisation therapy)
- People whose heart pumping function has dropped by more than 5%, or whose heart has increased in size by a certain amount, since their pacemaker was put in
- People with a blood test result (NT-proBNP) above 250 ng/L, if their heart is beating in a normal rhythm
- People with a blood test result (NT-proBNP) above 750 ng/L, if they have an irregular heart rhythm called atrial fibrillation
- People whose heart's left upper chamber has become enlarged beyond a certain measurement
- People who have been prescribed regular water tablets (diuretics) to manage fluid in their body
- People whose daily physical activity has dropped by more than one hour per day since their pacemaker was implanted
- People whose pacemaker device has recorded a decrease in fluid levels in the chest area
- People who have noticed a decline in their ability to exercise or carry out daily activities since their pacemaker was implanted
Who may not be able to join:
- People who are not able to give their own informed consent to participate
- People under the age of 18
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel Keene, PhD, Imperial College London
Phone: 07749576830
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
SF-36 (Short Form 36 Health Survey Questionnaire) Physical Component Summary
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.